Cord blood banking and transplantation: Advances and controversies

Current Opinion in Pediatrics

Volumn 26, Issue 2, 2014, Pages 163-168

  Yoder, Mervin C ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cord blood stem cell transplantation; Umbilical cord blood; Umbilical cord blood banking

Indexed keywords

BLOOD BANK; CORD BLOOD STEM CELL TRANSPLANTATION; ECONOMIC ASPECT; ENGRAFTMENT; ETHNIC GROUP; HUMAN; PRIORITY JOURNAL; RACE; REVIEW; STEM CELL EXPANSION; UMBILICAL CORD BLOOD; BLOOD; CHILD; CYTOLOGY; FANCONI ANEMIA; FEMALE; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MORTALITY; PATIENT SELECTION; PROCEDURES; SURVIVAL RATE; TRENDS;

BLOOD BANKS; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FANCONI ANEMIA; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PATIENT SELECTION; SURVIVAL RATE;

EID: 84897022504     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000065     Document Type: Review

References (43)

1. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013; 122:491-498.
2. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321:1174-1178.
3. Rubinstein P, Adamson JW, Stevens C. The placental/umbilical cord blood program of the New York Blood Center. A progress report. Ann N Y Acad Sci 1999; 872:328-334; discussion 34-35.
4. Gluckman E, Ruggeri A, Rocha V, et al. Family-directed umbilical cord blood banking. Haematologica 2011; 96:1700-1707.
5. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335:157-166.
6. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342:1846-1854.
7. Herr AL, Kabbara N, Bonfim CM, et al. Long-Term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: An analysis on behalf of Eurocord-EBMT. Blood 2010; 116:1849-1856.
8. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet 2007; 369:1947-1954.
9. Wagner JE, Eapen M, Carter SL, et al. No survival advantage after double umbilical cord blood (UCB) compared to single UCB transplant in children with hematological malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) randomized trial. ASH Ann Meeting Abstracts 2012; 120:359.
10. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344:1815-1822.
11. Cohen YC, Scaradavou A, Stevens CE, et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: A pooled analysis of three international registries. Bone Marrow Transplant 2011; 46:70-76.
12. Ooi J, Takahashi S, Tomonari A, et al. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia. Biol Blood Marrow Transplant 2008; 14:1341-1347.
13. Cutler C, Ballen KK. Improving outcomes in umbilical cord blood transplantation: State of the art. Blood Rev 2012; 26:241-246.
14. Cutler C, Stevenson K, Kim HT, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant 2011; 46:659-667.
15. Barker JN, Byam C, Scaradavou A. How I treat: The selection and acquisition of unrelated cord blood grafts. Blood 2011; 117:2332-2339.
16. Sauter C, Abboud M, Jia X, et al. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biol Blood Marrow Transplant 2011; 17:1460-1471.
17. Broxmeyer HE. Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function. Ann N Y Acad Sci 2012; 1266:151-160.
18. Delaney C, Bollard CM, Shpall EJ. Cord blood graft engineering. Biol Blood Marrow Transplant 2013; 19 (Suppl 1):S74-S78.
19. Delaney C, Varnum-Finney B, Aoyama K, et al. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 2005; 106:2693-2699.
20. Delaney C, Heimfeld S, Brashem-Stein C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16:232-236.
21. Robinson SN, Ng J, Niu T, et al. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant 2006; 37:359-366.
22. de Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 2012; 367:2305-2315.
23. de Lima M, McMannis J, Gee A, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: A phase I/II clinical trial. Bone Marrow Transplant 2008; 41:771-778.
24. Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010; 329:1345-1348.
25. Butler JM, Gars EJ, James DJ, et al. Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. Blood 2012; 120:1344-1347.
26. Corselli M, Chin CJ, Parekh C, et al. Perivascular support of human hematopoietic stem/progenitor cells. Blood 2013; 121:2891-2901.
27. Frassoni F, Gualandi F, Podesta M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol 2008; 9:831-839.
28. Rocha V, Labopin M, Ruggeri A, et al. Unrelated cord blood transplantation: Outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies. Transplantation 2013; 95:1284-1291.
29. Goessling W, Allen RS, Guan X, et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-Term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011; 8:445-458.
30. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113:5444-5455.
31. North TE, Goessling W, Walkley CR, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447:1007-1011.
32. Pelus LM, Hoggatt J, Singh P. Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Prolif 2011; 44 (Suppl 1):22-29.
33. Cutler C, Multani P, Robbins D, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 2013; 122:3074-3081.
34. Robinson SN, Simmons PJ, Thomas MW, et al. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rgamma(null) mice. Exp Hematol 2012; 40:445-456.
35. Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305:1000-1003.
36. Farag SS, Srivastava S, Messina-Graham S, et al. In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev 2013; 22:1007-1015.
37. Pelosi E, Castelli G, Testa U. Human umbilical cord is a unique and safe source of various types of stem cells suitable for treatment of hematological diseases and for regenerative medicine. Blood Cells Mol Dis 2012; 49:20-28.
38. Ilic D, Miere C, Lazic E. Umbilical cord blood stem cells: Clinical trials in nonhematological disorders. Br Med Bull 2012; 102:43-57.
39. Carroll J. Human cord blood for the hypoxic-ischemic neonate. Pediatric Res 2012; 71 (4 Pt 2):459-463.
40. Liao Y, Cotten M, Tan S, et al. Rescuing the neonatal brain from hypoxic injury with autologous cord blood. Bone Marrow Transpl 2013; 48:890-900.
41. Guindi ES. Public and private cord blood banking. In: Broxmeyer HE, editor. Cord blood: Biology, transplantation, banking, and regulation. Bethesda, MD: AABB Press; 2011. pp. 595-631.
42. Rosenthal J, Woolfrey AE, Pawlowska A, et al. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use. Pediatric Blood Cancer 2011; 56:1009-1012.
43. Wagner AM, Krenger W, Suter E, et al. High acceptance rate of hybrid allogeneic-Autologous umbilical cord blood banking among actual and potential Swiss donors. Transfusion 2013; 53:1510-1519.